Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

BACKGROUND: One quarter to one third of patients eligible for systemic thrombolysis are on antiplatelet therapy at presentation. In this study, we aimed to assess the safety and efficacy of intravenous thrombolysis in stroke patients on prescribed antiplatelet therapy in the WAKE-UP trial. METHODS:...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neurol Res Pract
Autori principali: Frey, Benedikt M., Boutitie, Florent, Cheng, Bastian, Cho, Tae-Hee, Ebinger, Martin, Endres, Matthias, Fiebach, Jochen B., Fiehler, Jens, Ford, Ian, Galinovic, Ivana, Königsberg, Alina, Puig, Josep, Roy, Pascal, Wouters, Anke, Magnus, Tim, Thijs, Vincent, Lemmens, Robin, Muir, Keith W., Nighoghossian, Norbert, Pedraza, Salvador, Simonsen, Claus Z., Gerloff, Christian, Thomalla, Götz
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7678217/
https://ncbi.nlm.nih.gov/pubmed/33324940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42466-020-00087-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi